What Is the Appropriate Treatment Strategy for MS Breakthrough Disease?December 1, 2008Multiple Sclerosis
Glatiramer Acetate Is Associated With Fewer MS Relapses and Lower Costs Than Interferon Beta-1bDecember 1, 2008Multiple Sclerosis
Exploring Viral, Environmental, and Immunologic Bases for Multiple SclerosisNovember 1, 2008Multiple Sclerosis
Reuters Health InformationOctober 1, 2008Alzheimer's & CognitionEpilepsy & SeizuresMultiple Sclerosis
Clinical Trial Digest: Findings from Recently Published Randomized Controlled TrialsSeptember 1, 2008Alzheimer's & CognitionEpilepsy & SeizuresMultiple SclerosisMovement DisordersStrokeParkinson's Disease
Can Neuropsychiatric Symptoms Be Predicted in Patients With MS and Cognitive Impairment?September 1, 2008Alzheimer's & CognitionMultiple Sclerosis
Do Current Outcome Measures Underestimate the Impact of Multiple Sclerosis?August 1, 2008Multiple Sclerosis
Advances in Neurogenetics, Neuromics Aid Understanding of Neurologic DisordersMay 1, 2008Alzheimer's & CognitionMultiple Sclerosis
